4-Bromo-3,5-dimethylaniline

Catalog No.: 
ACZDEA695
CAS No.: 
59557-90-3
Molecular Formula: 
C8H10BrN
Molecular Weight: 
200.08
4-Bromo-3,5-dimethylaniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$86.00In stockInquiry
500g98%$430.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-3,5-dimethylaniline
IUPAC Name4-bromo-3,5-dimethylaniline
MDL No.MFCD07780648
Molecular FormulaC8H10BrN
Molecular Weight200.08
SMILESNC1=CC(C)=C(Br)C(C)=C1
InChI KeyOGBPXDJLNYCSJH-UHFFFAOYSA-N
SynonymAKOS005133404 | AS-18438 | STK889370 | SB78466 | FT-0683270 | SCHEMBL525424 | MFCD07780648 | BCP21244 | (4-Bromo-3,5-dimethylphenyl)amine | Bromo-3,5-dimethylaniline | EN300-100804 | 4-Bromo-3,5-dimethyl-phenylamine | CS-W020003 | BBL025853 | Benzenamine,
CAS No.59557-90-3
PubChem CID12383117

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZDEA695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGWMJ358 route compound structure diagram
    ACGWMJ35853906-84-6In Stock
  2. Then
  3. ACZDEA695 route product structure diagram
    ACZDEA69559557-90-3In Stock
Inquiry

2. ACZDEA695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZDEA695 route product structure diagram
    ACZDEA69559557-90-3In Stock
Inquiry

3. ACZDEA695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZDEA695 route product structure diagram
    ACZDEA69559557-90-3In Stock
Inquiry

Comments (0)